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Neurofibromatosis type 1 (NF1;OMIM162200) is an autosomal dominant disorder caused by awide
variety of germline mutations in the NF1 gene. Nearly all individuals with NF1 exhibit café-au-lait
macules before the age of 2,1 but can also develop numerous othermedical problems, including autism,
cognitive deficits, tumors, and congenital heart defects. Although the clinical variability inherent inNF1
has been attributed to stochastic events, it is possible that the specific germlineNF1mutationmight be
one factor underlying this heterogeneity. To illustrate this point, we report a family with 2 affected
members harboring a missense mutation in the NF1 gene who lack the classic features of NF1.
The proband came to medical attention for failure to thrive, hypotonia, global delay, projectile
vomiting, and feeding problems, necessitating the placement of a gastrostomy tube at 9months of age.
Although the pregnancy and vaginal delivery at 39 weeks of gestation were uncomplicated, soon after
birth, a patent foramen ovale and pulmonic valve stenosis were noted. Because her father had several
cutaneousmasses, later pathologically determined to be lipomas, the patient underwent chromosomal
microarray (normal) and NF1 genetic testing, revealing a c.3445A>G (p.Met1149Val) germline
mutation in theNF1 gene, which was paternally inherited based on parental NF1 genetic testing. Her
father had no Lisch nodules, café-au-lait macules, or skinfold freckling. The patient also had no café-
au-lait macules or skinfold freckling at 20 months of age, but had 2 mobile subcutaneous nodular
masses on her left chest, suggestive of neurofibromas. No plexiform neurofibromas were appreciated
on either the patient or her father, and noothermembers of their extended family had features ofNF1.
The patient underwent brain and total spine neuroimaging, based on a left-hand preference, axial
hypotonia and a reluctance to bear weight on her legs, which were completely normal.
The finding of a germline NF1 mutation in this family raises several important points. First, this
missense mutation results in a methionine to valine change in an amino acid residue conserved in
vertebrates and flies and predicted to be pathogenic using both PolyPhen (isoform-1, possibly_
damaging, 0.557; isoform-2, probably_damaging, 0.909) and SIFT (both isoforms, deleterious, 0)
variant pathogenicity analysis programs.Of interest, themutated amino acid is 59 to the RASGTPase
activating protein-related domain and is located within a segment involved in tubulin binding and
neurofibromin homodimerization (residues 1,085–1,172).2 This variant has a frequency of 1 in
251,376 alleles in control individuals (0.000003978; gnomADdatabase). It has also been reported in
a 56-year-old woman with malignant melanoma whose tumor harbored both the Met1149Val
mutation and another NF1 mutation, creating a premature protein truncation (Leu1109X) within
the same domain and resulting in 5% of normal NF1 gene expression (cBioPortal).3 For these
reasons, it is highly likely that the Met1149Val mutation is pathogenic in this family.
Second, although this family did not have NF1, patients with NF1 and Met1149Val NF1 gene
mutations tend to exhibit a mild clinical phenotype, with a paucity of optic gliomas or plexiform
neurofibromas.4 In contrast to the family reported herein, of the 48 patients with clinical assessments,4
94% had greater than 5 café-au-lait macules: Only 2 of these individuals had lipomas, and only 1 had
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pulmonic stenosis. The finding of thismutation in a family without
NF1 extends the spectrumof clinicalmanifestations that likely arise
from Met1149Val mutation.
Third, the lack of classic features of NF1 in these 2 individuals
add to the growing list of specific genotype-phenotype correla-
tions in patients withNF1, including patients harboring Arg1809
missense and Met991 codon deletion mutations who do not
develop optic gliomas or neurofibromas.4 Similarly, patients with
missensemutations located in residues spanning 844 to 848 have
been reported to exhibit more severe disease complications.5 As
the differential effects of specific germline NF1 gene mutations
become elucidated, it is possible that they will help to define
specific contact points for neurofibromin binding partners that
underlie these unique effects.
Finally, previous work from our laboratory has shown that dif-
ferent germline NF1 gene mutations create dissimilar biological
effects. Using human-induced pluripotent stem cells and mice
genetically engineered with NF1 patient NF1 gene mutations,
we found striking differences in neuronal differentiation6 and
optic glioma formation.7 Surprisingly, this variability was not the
result of different levels of RAS hyperactivation, but rather
reflected other functions of neurofibromin, some of which re-
main to be defined. These observations suggest that other
readouts for neurofibromin activity, besides RAS pathway sig-
naling, are needed to characterize the contributions of different
germline NF1 gene mutations to human disease pathobiology.
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